Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IkappaB
Glaus Garzon, Jesus F.
Oertli, Carole I.
Richards, Peter J.
Hottiger, Michael O.
Wenger, Roland H.
- Journal Article
Rights / licenseCreative Commons Attribution 3.0 Unported
Two main features common to all solid tumors are tissue hypoxia and inflammation, both of which cause tumor progression, metastasis, therapy resistance and increased mortality. Chronic inflammation is associated with increased cancer risk, as demonstrated for inflammatory bowel disease patients developing colon cancer. However, the interplay between hypoxia and inflammation on the molecular level remains to be elucidated. We found that MC-38 mouse colon cancer cells contain functional hypoxic (HIF-1α) and inflammatory (p65/RelA) signaling pathways. In contrast to cells of the myeloid lineage, HIF-1α levels remained unaffected in MC-38 cells treated with LPS, and hypoxia failed to induce NF-κB. A similar regulation of canonical HIF and NF-κB target genes confirmed these results. RNA deep sequencing of HIF-1α and p65/RelA knock-down cells revealed that a surprisingly large fraction of HIF target genes required p65/RelA for hypoxic regulation and a number of p65/RelA target genes required HIF-1α for proinflammatory regulation, respectively. Hypoxia attenuated the inflammatory response to LPS by inhibiting nuclear translocation of p65/RelA independently of HIF-1α, which was associated with enhanced IκBα levels and decreased IKKβ phosphorylation. These data demonstrate that the interaction between hypoxic and inflammatory signaling pathways needs to be considered when designing cancer therapies targeting HIF or NF-κB. Show more
Journal / seriesOncotarget
Pages / Article No.
PublisherImpact Journals LLC
Subjectinflammatory bowel disease; lipopolysaccharide; NF-κB; tissue oxygenation; tumor hypoxia
Organisational unit02207 - Functional Genomics Center Zürich / Functional Genomics Center Zürich
MoreShow all metadata